EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells

Beatriz Pinheiro Lopes iD, Liam O'Neill iD, Paula Bourke iD, Daniela Boehm

Cancers · 05.10.2023 · 15 (19) · 4858

DOI: 10.3390/cancers15194858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 05.10.2023. Verfasst von Beatriz Pinheiro Lopes und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Bioprocess Engineering, University College Dublin, D04 V1W8 Dublin, Ireland. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Research Council, Irish Research Council under the Enterprise Partnership Scheme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increase in cancer diagnoses and cancer deaths, severe side effects of existing treatments and resistance to traditional treatments have generated a need for new anticancer treatments. Glioblastoma multiforme (GBM) is the most common, malignant and aggressive brain cancer. Despite many innovations regarding GBM treatment, the final outcome is still very poor, making it necessary to develop new therapeutic approaches. Cold atmospheric plasma (CAP) as well as plasma-activated liquids (PAL) are being studied as new possible approaches against cancer. The anticancer activity of PAL such as “plasma-activated water” (PAW) is dependent on the reactive chemical compounds present in the solution. Possible combinatory effects with conventional therapies, such as chemotherapeutics, may expand the potential of PAL for cancer treatment. We aim to explore the therapeutic properties of a combination of PAW and topotecan (TPT), an antineoplastic agent with major cytotoxic effects during the S phase of the cell cycle, on a GBM cancer cell line (U-251mg). Combined treatments with PAW and TPT showed a reduction in the metabolic activity and cell mass, an increase in apoptotic cell death and a reduction in the long-term survival. Single applications of PAW+TPT treatments showed a cytotoxic effect in the short term and an antiproliferative effect in the long term, warranting future exploration of combining PAW with chemotherapeutic agents as new therapeutic approaches.

Schlagwörter

Stichwörter der Autor:innen

anticancer treatmentcombination treatmentsglioblastomaplasma-activated waterreactive speciestopotecan

Autor:innen und Institutionen

  • School of Chemical and Bioprocess Engineering, University College Dublin, D04 V1W8 Dublin, Ireland.
  • Environmental Sustainability and Health Institute and School of Food Science and Environmental Health, Technological University Dublin, D07 H6K8 Dublin, Ireland.
  • TheraDep Ltd., QUESTUM Innovation Centre, Limerick Institute of Technology, E91 V329 Clonmel, Ireland.
  • Plasma Research Group, School of Biosystems and Food Engineering, University College Dublin, D04 V1W8 Dublin, Ireland.
  • Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland.

ORCID-Profile: Beatriz Pinheiro Lopes, Liam O'Neill, Paula Bourke

Förderung

  • Irish Research Council
  • Irish Research Council under the Enterprise Partnership Scheme

Zitieren

APA

Pinheiro Lopes, B., O'Neill, L., Bourke, P., & Boehm, D. (2023). Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells. Cancers, 15(19), 4858. https://doi.org/10.3390/cancers15194858

Vancouver

Pinheiro Lopes B, O'Neill L, Bourke P, Boehm D. Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells. Cancers. 2023;15(19):4858. doi:10.3390/cancers15194858

BibTeX
@article{PinheiroLopes2023,
  author = {Pinheiro Lopes, Beatriz and O'Neill, Liam and Bourke, Paula and Boehm, Daniela},
  title = {Combined Effect of Plasma-Activated Water and Topotecan in Glioblastoma Cells},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {19},
  pages = {4858},
  doi = {10.3390/cancers15194858}
}
Kostenlos starten →